BEIJING, June 11

A COVID-19 vaccine from Sinopharm unit Beijing Institute of Biological Products has obtained approval to be used on people aged between three and 17 in China, a disease control official said on Friday.

Related Articles

​​​​​​​The government has decided to start the second round of Covid-19 vaccination drive to administer the second dose of vaccine from April 20. Photo: Skanda Gautam/THT/File

Second-dose of Covid-19 vaccine from Tuesday

Ministry of Health and Population (MoHP), in Kathmandu. Photo Courtesy: MoHP

Govt starts inoculation with China-donated Covid-19 vaccine 'Vero Cell' from today

Shao Yiming, a researcher at the Chinese Center for Disease Control and Prevention, was speaking to reporters at a news briefing.